Peptique

PeptiquePeptique
P

Peptique

AI-powered platform for personalized peptide design and synthesis for drug discovery.

DR 0ActiveCambridge, United States
Rate

About

Peptique is developing an AI-driven platform that accelerates drug discovery by enabling the rapid design, synthesis, and testing of novel peptides. Their technology leverages machine learning to predict peptide efficacy and optimize synthesis processes, significantly reducing the time and cost associated with traditional drug development.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Peptique do?

Peptique is developing an AI-driven platform that accelerates drug discovery by enabling the rapid design, synthesis, and testing of novel peptides. Their technology leverages machine learning to predict peptide efficacy and optimize synthesis processes, significantly reducing the time and cost associated with traditional drug development.

How much funding has Peptique raised?

Peptique has raised a total of $2M in funding. The most recent round on record is Seed.

Where is Peptique headquartered?

Peptique is headquartered in Cambridge, United States.

What industry does Peptique operate in?

Peptique operates in AI-Driven Protein Design, Drug Discovery, Biotech, Foundation Model, Generative AI, Machine Learning.

What is Peptique's revenue?

StartupHub estimates Peptique's annual revenue at $190K (range $50K to $227K, 27% confidence), based on comparable companies in the sector.

What is Peptique's valuation?

StartupHub estimates Peptique's effective valuation at $5.4M (range $3.8M to $9.0M, 10% confidence), based on comparable companies in the sector.